← Back to directory

Vincent Soriano

Researcher Next ID · RN-035144

Researcher · Immunology and Microbiology

Fundación Instituto Valenciano de Oncología

Valencia, Spain

Accepting doctoral researchersFunding unknown
Works count
1,174
Citation count
36,381
H-index
91
i10-index
633

Research interests

Immunology and Microbiology
Medicine
HIV/AIDS drug development and treatment
Hepatitis C virus research
HIV Research and Treatment
Hepatitis B Virus Studies
HIV/AIDS Research and Interventions

Publications

  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Setting-specific Transmission Rates: A Systematic Review and Meta-analysis

    Clinical Infectious Diseases · 2021 · 10.1093/cid/ciab100

  • Update of the statements on biology and clinical impact of occult hepatitis B virus infection

    Journal of Hepatology · 2019 · https://doi.org/10.1016/j.jhep.2019.03.034

  • Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis

    PLoS Medicine · 2015 · 10.1371/journal.pmed.1001810

  • Faldaprevir and Deleobuvir for HCV Genotype 1 Infection

    New England Journal of Medicine · 2013 · 10.1056/nejmoa1213557

  • Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study

    The Journal of Infectious Diseases · 2012 · https://doi.org/10.1093/infdis/jis750

  • A germline variant in the TP53 polyadenylation signal confers cancer susceptibility

    Nature Genetics · 2011 · 10.1038/ng.926

  • European guidelines on the clinical management of HIV-1 tropism testing

    The Lancet Infectious Diseases · 2011 · https://doi.org/10.1016/s1473-3099(10)70319-4

  • The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*

    Journal of Viral Hepatitis · 2011 · 10.1111/j.1365-2893.2011.01499.x

  • Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs

    The Lancet · 2010 · 10.1016/s0140-6736(10)60829-x

  • Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

    AIDS · 2009 · https://doi.org/10.1097/qad.0b013e3283262a64

  • Predictors of Kidney Tubular Dysfunction in HIV‐Infected Patients Treated with Tenofovir: A Pharmacogenetic Study

    Clinical Infectious Diseases · 2009 · 10.1086/598507

  • New common variants affecting susceptibility to basal cell carcinoma

    Nature Genetics · 2009 · https://doi.org/10.1038/ng.412

  • ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma

    Nature Genetics · 2008 · 10.1038/ng.161

  • European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV‐infected adults

    HIV Medicine · 2008 · 10.1111/j.1468-1293.2007.00535.x

  • Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV–HIV International Panel

    AIDS · 2007 · 10.1097/qad.0b013e3281084e4d

  • Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral Therapy

    The Journal of Infectious Diseases · 2005 · https://doi.org/10.1086/432762

  • Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

    The Journal of Infectious Diseases · 2005 · https://doi.org/10.1086/432916

  • Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration

    PLoS Medicine · 2005 · https://doi.org/10.1371/journal.pmed.0020112

  • Selection of Hepatitis B Virus Polymerase Mutations in HIV-Coinfected Patients Treated with Tenofovir

    Antiviral Therapy · 2005 · 10.1177/135965350501000612

  • Hepatocellular carcinoma in HIV-infected patients

    AIDS · 2004 · 10.1097/00002030-200411190-00009

  • Care of patients with hepatitis C and HIV co-infection

    AIDS · 2004 · 10.1097/00002030-200401020-00001

  • Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus–Infected Patients with Chronic Hepatitis C: A European Collaborative Study

    Clinical Infectious Diseases · 2003 · 10.1086/380130

  • Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel

    AIDS · 2002 · https://doi.org/10.1097/00002030-200204120-00001

  • Risk Factors for Severe Hepatic Injury After Introduction of Highly Active Antiretroviral Therapy

    JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 10.1097/00126334-200108150-00002

  • Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain

    AIDS · 1998 · 10.1097/00002030-199809000-00008

Current projects

    No projects listed.